News

As per the agreement, Novartis received an upfront fee and will receive royalties on net sales of Proleukin in the US. Novartis is also eligible to receive potential

In the US, Victoza is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. This provides for Victoza to

NMS Labs said that this is a timely release due to the FDA’s recent reversal of its position on BPA’s potentially harmful effects and the National Toxicology Program’s

Morphine Sulfate Oral Solution CII is indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. The company

If the specific aims of this grant are achieved, the company could receive additional research dollars from the NIH to discover potential drug targets for the treatment of

The company-owned 30,000 square-foot facility is expected to provide clients with access to multiple clean room manufacturing suites, each with independent air-handling and laboratory systems, to support PCT’s

The company has introduced additional capacity that will address the immediate demand for the Illumina sequencing services. This investment will provide increased throughput, reliability and process security to

5-fluorouracil (5-FU) is used in many chemotherapy regimens, including FOLFOX (folinic acid, fluorouracil and oxaliplatin), FOLFOX6, and FOLFIRI (folinic acid, fluorouracil and irinotecan), and is used extensively in

Under the agreement, Envoy will use its proprietary bacTRAP technology to identify proteins expressed specifically in certain cell types. Merck will then work to identify and develop compounds